Biote Corp.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Biote Corp. now
Current reporting with the operating signal separated from the noise.
Biote Corp. Balances Recall Hit With Growth Plans
The story matters when it changes Biote Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.biote Corp. (BTMD) Q1 2026 Earnings Call Transcript
Investors are testing whether Biote Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.biote Corp. (BTMD) Q4 2025 Earnings Call Transcript
Investors are testing whether Biote Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.What To Expect From Biote Corp (BTMD) Q4 2025 Earnings
Investors are testing whether Biote Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.biote Corp. (BTMD) Tops Q2 Earnings Estimates
Investors are testing whether Biote Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Biote Corp. (BTMD) Q1 Earnings and Revenues Surpass Estimates
Investors are testing whether Biote Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.biote Corp. (BTMD): Insider Were Buying In Q1 2025
The story matters when it changes Biote Corp.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Biote Corp. (BTMD) Beats Q3 Earnings Estimates
Investors are testing whether Biote Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Biote Corp CFO sells over $200k in company stock
Investors are testing whether Biote Corp.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest BTMD filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Biote Corp., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.